Jablonska et al, 2014 (18)
|
ACB
|
A-no apparent confounding
|
C-no information about controls recruitment
|
I1:A-cases confirmed by antibody assay and PCR
I2:B-antibody negative controls
I3:A-genotyping QC reported
|
Taniguchi et al, 2013 (19)
|
CBC
|
C-no information whether controls were matched to cases
|
B-controls drawn from database (to represent general population)
|
I1:B-majority of cases confirmed by clinical status and urine-filter based screening, only few confirmed by PCR
I2:C-no description of disease status in controls
I3:A-genotyping QC reported
|
Wujcicka et al, 2015 (20)
|
ABC
|
A-no apparent confounding
|
B-hospital based
|
I1:A-cases confirmed by serological tests and qPCR
I2:C-not reported clearly how controls were confirmed as uninfected
I3:A-genotyping QC reported
|
Hu et al, 2010 (21)
|
ACC
|
A-no apparent confounding
|
C-no information about controls recruitment
|
I1:A-cases confirmed by qPCR and antibody assay
I2:B-antibody negative controls
I3:C-no genotyping QC reported
|
Szala et al, 2011 (22) |
ABC |
A-no apparent confounding |
B-hospital based |
I1:B-cases confirmed by qPCR and/or antibody assay
I2:C-not reported clearly how controls were confirmed as uninfected
I3:C-no genotyping QC reported |